核内IL-33在IL-4和IL-13抑制角质形成细胞分化标志物中的作用
该研究探讨核内IL-33是否参与IL-4/IL-13抑制角质形成细胞分化的过程。在单层培养和活体皮肤等效物中,IL-4/IL-13通过MAPK/ERK通路增加核内全长IL-33,后者作为STAT3转录辅因子抑制FLG转录,并通过STAT3/STAT6抑制RUNX1下调LOR、K1和K10。
要点
- IL-4/IL-13通过MAPK/ERK通路增加角质形成细胞核内全长IL-33。
- 核内IL-33作为STAT3辅因子增强p-STAT3与FLG启动子结合并抑制转录。
- 核内IL-33经STAT3/STAT6抑制RUNX1,下调LOR、K1和K10。
核心结论
- AD皮损表皮中升高的核内IL-33可能通过抑制角质形成细胞分化和皮肤屏障功能参与AD发病。
研究设计与样本
- 研究采用单层培养和活体皮肤等效物分析,检测IL-4和IL-13对核内IL-33及分化标志物的影响。
主要发现
- IL-4和IL-13激活MAPK/ERK信号通路,增加角质形成细胞核内全长IL-33表达,该通路为抑制分化标志物所必需。
- 核内IL-33作为STAT3转录辅因子,增加磷酸化STAT3与FLG启动子结合,抑制FLG转录。
- 核内IL-33通过STAT3和STAT6抑制转录因子RUNX1表达,下调LOR、角质蛋白1和角质蛋白10。
临床怎么用
- 提示靶向核内IL-33或其下游STAT3/RUNX1通路可能改善AD皮肤屏障功能障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IL-33 is a chromatin-associated multifunctional cytokine implicated in the pathogenesis of atopic dermatitis (AD), an inflammatory skin disorder characterized by skin barrier dysfunction. The previous reports show that IL-33 is highly detected in the nucleus of epidermal keratinocytes in AD lesions compared with that in unaffected or normal skin. However, it is unclear whether intracellular IL-33 directly contributes to the pathogenesis of AD. T helper type 2 cytokines IL-4 and IL-13 that are elevated in AD lesions suppress keratinocyte differentiation to impair skin barrier function. We investigated whether intracellular IL-33 is involved in IL-4 and IL-13 function. In monolayer culture and living skin equivalent analyses, IL-4 and IL-13 increased the expression of full-length IL-33 in the nucleus of keratinocytes by activating the MAPK/extracellular signal‒regulated kinase kinase/extracellular signal‒regulated kinase signaling pathway, which is necessary for the inhibition of differentiation markers FLG, LOR, keratin 1, and keratin 10. The nuclear IL-33 functions as a transcription cofactor of signal transducer and activator of transcription 3, increasing the binding of phosphorylated signal transducer and activator of transcription 3 to FLG promoter, thereby inhibiting its transcription, and it inhibits the expression of transcription factor RUNX1 by signal transducer and activator of transcription 3 and signal transducer and activator of transcription 6, thereby downregulating LOR, keratin 1, and keratin 10. Thus, the elevated nuclear IL-33 in the epidermis of AD lesions may be involved in the pathogenesis of AD by inhibiting keratinocyte differentiation and skin barrier function.
引用
- Dai X, Utsunomiya R, Shiraishi K, et al. Nuclear IL-33 Plays an Important Role in the Suppression of FLG, LOR, Keratin 1, and Keratin 10 by IL-4 and IL-13 in Human Keratinocytes. J Invest Dermatol. 2021. PMID: 33865911. doi:10.1016/j.jid.2021.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。